Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $130,476 - $163,627
-180 Reduced 13.38%
1,165 $1.05 Million
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $790,587 - $1.06 Million
1,335 Added 13350.0%
1,345 $1.05 Million
Q4 2023

Feb 07, 2024

SELL
$525.19 - $619.13 $129,196 - $152,305
-246 Reduced 96.09%
10 $5,000
Q3 2023

Nov 27, 2023

BUY
$434.7 - $599.3 $109,979 - $151,622
253 Added 8433.33%
256 $137,000
Q2 2023

Nov 27, 2023

SELL
$350.74 - $468.98 $22,096 - $29,545
-63 Reduced 95.45%
3 $1,000
Q1 2023

Nov 27, 2023

SELL
$310.63 - $364.82 $1.13 Million - $1.33 Million
-3,633 Reduced 98.22%
66 $22,000
Q3 2022

Oct 24, 2022

BUY
$296.48 - $337.87 $1.1 Million - $1.25 Million
3,696 Added 123200.0%
3,699 $1.2 Million
Q1 2022

Aug 16, 2022

SELL
$234.69 - $291.66 $3,989 - $4,958
-17 Reduced 85.0%
3 $1,000
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $42,721 - $53,017
-190 Reduced 90.48%
20 $6,000
Q3 2021

Nov 08, 2021

SELL
$221.6 - $272.71 $16,620 - $20,453
-75 Reduced 26.32%
210 $49,000
Q2 2021

Jul 29, 2021

SELL
$180.55 - $233.54 $17,332 - $22,419
-96 Reduced 25.2%
285 $65,000
Q1 2021

May 06, 2021

BUY
$164.32 - $212.72 $62,112 - $80,408
378 Added 12600.0%
381 $71,000
Q4 2020

Jan 29, 2021

SELL
$130.46 - $172.63 $1.01 Million - $1.34 Million
-7,745 Reduced 99.96%
3 $1,000
Q3 2020

Oct 09, 2020

SELL
$146.22 - $169.13 $920,308 - $1.06 Million
-6,294 Reduced 44.82%
7,748 $1.15 Million
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $1.92 Million - $2.3 Million
14,039 Added 467966.66%
14,042 $2.31 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $320 - $348
3 New
3 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.